Use of glatiramer acetate

MSMED_GLATIRAMERACETATE

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC L03AX13

500

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

413

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

413

diagram downward connector

Include endpoints None

413

diagram downward connector
MSMED_GLATIRAMERACETATE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

Key figures

All Female Male
Number of individuals 413 338 75
Unadjusted prevalence (%) 0.12 0.17 0.05
Mean age at first event (years) 39.56 38.87 42.68

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: MSMED_GLATIRAMERACETATE – Use of glatiramer acetate
GWS hits:

Survival analyses between endpoints

Plot

before Use of glatiramer acetate
after Use of glatiramer acetate

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of glatiramer acetate